Successful macular hole closure

Article

It is not necessary for patients to remain face-down for more than 24 hours to ensure successful macular hole closure, according to study results published online ahead of print by the British Journal of Ophthalmology.

It is not necessary for patients to remain face-down for more than 24 hours to ensure successful macular hole closure, according to study results published online ahead of print by the British Journal of Ophthalmology.

Judy E. Kim of the Medical College of Wisconsin, United States and colleagues conducted a 15-month multicentre review of patients (n=53; eyes, n=56) undergoing consecutive stage 3 and 4 macular hole surgeries. Mean preoperative visual acuity was 0.74 logMAR (20/100 Snellen). Surgery was not routinely combined with phacoemulsification, but internal limiting membrane (ILM) peeling, using either SF6 or C3F8 gas tamponade, was conducted in 49 eyes. Of the eyes undergoing surgery, 79% had stage 3 macular holes and 70% were phakic.

Macular hole closure was achieved by just one operation in 93% of eyes (n=52). Mean postoperative visual acuity was 0.41 logMAR (20/50 Snellen). The mean follow-up period was 5.2 months.

Therefore the researchers concluded that - since macular hole closure was achieved in the majority of cases by just one operation with only one day of prone positioning - sustained prone positioning is not necessary for successful hole closure.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
© 2025 MJH Life Sciences

All rights reserved.